DIAMOND BIOFUND (6901) reported revenue of -NT$689.7 million for Oct 2026, -302.0% from the previous month. Revenue for Jan–Oct 2026 was NT$1.86 billion.
In Oct 2026, it ranked No. 101 by revenue among 103 Others companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | -NT$689.7 million | — | -302.0% |
| Sep 2026 | NT$341.5 million | — | +24,715.2% |
| Aug 2026 | NT$1.4 million | -87.7% | — |
| Jul 2026 | -NT$926.9 million | — | -142.0% |
| Jun 2026 | NT$2.21 billion | +4,396.6% | +218.5% |
| May 2026 | NT$692.7 million | — | +22.3% |
| Apr 2026 | NT$566.2 million | — | — |
| Mar 2026 | -NT$84.9 million | — | — |
| Feb 2026 | -NT$235.1 million | -157.4% | — |
| Jan 2026 | -NT$16.2 million | — | -115.1% |
| Dec 2025 | NT$107.8 million | -8.6% | +212.4% |
| Nov 2025 | NT$34.5 million | — | — |
| Oct 2025 | -NT$125.9 million | — | — |
| Sep 2025 | -NT$39.7 million | — | -454.0% |
| Aug 2025 | NT$11.2 million | -88.7% | — |
| Jul 2025 | -NT$93.6 million | — | -290.7% |
| Jun 2025 | NT$49.1 million | -93.0% | — |
| May 2025 | -NT$225.3 million | — | — |
| Apr 2025 | -NT$245 million | — | — |
| Mar 2025 | -NT$646.6 million | — | -257.9% |
| Feb 2025 | NT$409.5 million | +353.1% | — |
| Jan 2025 | -NT$309.2 million | — | -362.1% |
| Dec 2024 | NT$118 million | — | — |
| Nov 2024 | -NT$161.1 million | -149.0% | — |
| Oct 2024 | -NT$564.6 million | -347.1% | — |
Jan–Oct 2026 cumulative: NT$1.86 billion (— YoY)
Other Others companies
Compare with peers: DIAMOND BIOFUND vs CTCI / DIAMOND BIOFUND vs Chailease / DIAMOND BIOFUND vs RUENTEX DEVELOP
| Company | Revenue | YoY |
|---|---|---|
| CTCI | NT$9.02 billion | +53.9% |
| Chailease | NT$8.39 billion | +3.6% |
| RUENTEX DEVELOP | NT$4.25 billion | +47.7% |
| TAC | NT$3.24 billion | +2.4% |
| TON YI | NT$2.79 billion | -2.2% |
| HLC | NT$2.56 billion | -3.9% |
| HON CHUAN | NT$2.41 billion | +18.3% |
| HOTAI FINANCE | NT$1.9 billion | -0.8% |
Company remark (original Chinese)
營業收入為股利收入及投資標的之評價損益(含已實現及未實現),投資標的股數及公允價值變動情形,請參考本公司網站投資人專區。
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16